A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf
.
Comparison of the effects of Propofol, Dexmedetomidine and Midazolam on Sedation and Oxidative-Antioxidant System in Critically ill Patients
2022
Zenodo
This study aimed to compare the impact of midazolam, propofol, dexmedetomidine infusions for 24th hour on total antioxidant status (TAS), total oxidant status (TOS), oxidative stres index (OSI) and prolidase levels. Material and Method: 75 patient ICU patient who were mechanically ventilated enrolled to the study. Patients randomised to three groups. Group I (n=25, midazolam): 0.02 mg/ kg/h midazolam, Group II (n = 25, propofol): 1mg/kg/h propofol, Group III (n=25, dexmedetomidine): 0.2 µg/
doi:10.5281/zenodo.7239284
fatcat:c3d6vcj6wffphc3keqenshixsy